메뉴 건너뛰기
European Journal of Nuclear Medicine and Molecular Imaging
Volumn 38, Issue 2, 2011, Pages 271-273
The best radionuclide for radioimmunotherapy of small tumors: Beta- or alpha-emitter?
Author keywords

[No Author keywords available]
Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID TYROSINE OCTREOTATE LU 177; ANTIBODY BI 213; ANTIBODY LT 177; ANTINEOPLASTIC AGENT; BISMUTH 213; CARCINOEMBRYONIC ANTIGEN ANTIBODY I 31; D9 MONOCLONAL ANTIBODY; D9 MONOCLONAL ANTIBODY LU 177; IODINE 131; LEWIS Y ANTIBODY LU 177; LUTETIUM 177; MONOCLONAL ANTIBODY; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; TENASCIN ANTIBODY AT 211; TOSITUMOMAB I 131; UNCLASSIFIED DRUG; YTTRIUM 90;
EID: 79551568406     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1707-7     Document Type: Note
Times cited : (10)
References (11)
  • 3
    • 33749043460 scopus 로고    scopus 로고
    • Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose
    • 1:CAS:528:DC%2BD28XptVajsro%3D 16883015
    • J Elgqvist H Andersson T Bäck, et al. 2006 Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: outcome related to measured tumor size and mean absorbed dose J Nucl Med 47 1342 1350 1:CAS:528:DC%2BD28XptVajsro%3D 16883015
    • (2006) J Nucl Med , vol.47 , pp. 1342-1350
    • Elgqvist, J.1    Andersson, H.2    Bäck, T.3
  • 7
    • 33846417642 scopus 로고    scopus 로고
    • 177Lu]pertuzumab: Experimental therapy of HER-2-expressing xenografts
    • DOI 10.1158/0008-5472.CAN-06-2363
    • M Persson L Gedda H Lundqvist V Tolmachev H Nordgren PU Malmström, et al. 2007 177Lu pertuzumab: experimental therapy of HER-2-expressing xenografts Cancer Res 67 326 331 1:CAS:528:DC%2BD2sXisFSrsA%3D%3D 10.1158/0008-5472.CAN-06-2363 17210714 (Pubitemid 46142791)
    • (2007) Cancer Research , vol.67 , Issue.1 , pp. 326-331
    • Persson, M.1    Gedda, L.2    Lundqvist, H.3    Tolmachev, V.4    Nordgren, H.5    Malmstrom, P.-U.6    Carlsson, J.7
  • 8
    • 58149334926 scopus 로고    scopus 로고
    • 177Lu-CHX-A-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGRF inhibition or docetaxel chemotherapy
    • 1:CAS:528:DC%2BD1MXhsFCns7o%3D 10.1002/pros.20856 18942092
    • 177Lu-CHX-A-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGRF inhibition or docetaxel chemotherapy Prostate 69 92 104 1:CAS:528:DC%2BD1MXhsFCns7o%3D 10.1002/pros.20856 18942092
    • (2009) Prostate , vol.69 , pp. 92-104
    • Kelly, M.P.1    Lee, S.T.2    Lee, F.T.3    Smyth, F.E.4    Davis, I.D.5    Brechbiel, M.6
  • 9
    • 4043111337 scopus 로고    scopus 로고
    • 177Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin
    • 1:CAS:528:DC%2BD2cXnsFygsb0%3D 15235070
    • 177Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin J Nucl Med 45 1224 1232 1:CAS:528: DC%2BD2cXnsFygsb0%3D 15235070
    • (2004) J Nucl Med , vol.45 , pp. 1224-1232
    • Koppe, M.J.1    Bleichrodt, R.P.2    Soede, A.C.3    Verhofstad, A.A.4    Goldenberg, D.M.5    Oyen, W.J.G.6
  • 11
    • 43749091955 scopus 로고    scopus 로고
    • Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate: Toxicity, efficacy, and survival
    • 1:CAS:528:DC%2BD1cXms1Ort7s%3D 10.1200/JCO.2007.15.2553 18445841
    • DJ Kwekkeboom WW de Herder BL Kam CH van Eijck M van Essen PP Kooij, et al. 2008 Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate: toxicity, efficacy, and survival J Clin Oncol 26 2124 2130 1:CAS:528:DC%2BD1cXms1Ort7s%3D 10.1200/JCO.2007.15.2553 18445841
    • (2008) J Clin Oncol , vol.26 , pp. 2124-2130
    • Kwekkeboom, D.J.1    De Herder, W.W.2    Kam, B.L.3    Van Eijck, C.H.4    Van Essen, M.5    Kooij, P.P.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.